NCT01545570View on ClinicalTrials.gov

A Study to Determine the Safety, Tolerability, and Effects of GSK2374697 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

82

Participants

Timeline

Start Date

November 7, 2011

Primary Completion Date

December 23, 2012

Study Completion Date

December 23, 2012

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

GSK2376497

GSK2376497 Active Comparator

DRUG

0.9% sodium chloride

0.9% sodium chloride Placebo Comparator

Trial Locations (1)

55404

GSK Investigational Site, Minneapolis

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01545570 - A Study to Determine the Safety, Tolerability, and Effects of GSK2374697 in Healthy Volunteers | Biotech Hunter | Biotech Hunter